WP
JAZZ icon

Woodline Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Woodline Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.2M Buy
+150,083
New +$32.9M 0.11% 240
2026
Q1 		– Sell
-41,222
Closed -$7.01M – 1104
2025
Q4 		$7.01M Sell
41,222
-223,746
-84% -$34.3M 0.03% 547
2025
Q3 		$34.9M Buy
264,968
+232,284
+711% +$27.9M 0.16% 169
2025
Q2 		$3.47M Sell
32,684
-69,366
-68% -$7.54M 0.02% 623
2025
Q1 		$12.7M Buy
102,050
+24,486
+32% +$3.19M 0.08% 318
2024
Q4 		$9.55M Sell
77,564
-201,644
-72% -$23.8M 0.06% 353
2024
Q3 		$31.1M Buy
279,208
+276,619
+10,684% +$30.3M 0.26% 126
2024
Q2 		$276K Buy
+2,589
New +$285K ﹤0.01% 522
2023
Q1 		– Sell
-60,443
Closed -$9.63M – 706
2022
Q4 		$9.63M Sell
60,443
-4,159
-6% -$610K 0.13% 217
2022
Q3 		$8.61M Sell
64,602
-332,259
-84% -$50.5M 0.12% 216
2022
Q2 		$61.9M Buy
396,861
+221,818
+127% +$34.1M 0.95% 11
2022
Q1 		$27.2M Buy
+175,043
New +$25.4M 0.44% 65
2020
Q3 		– Sell
-103,804
Closed -$11.5M – 195
2020
Q2 		$11.5M Buy
+103,804
New +$11.5M 0.45% 66

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Woodline Partners's JAZZ Position: Q2 2026 in Review

Woodline Partners opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 150,083 shares worth $36.2M. The stake represents 0.11% of the portfolio and ranks #240 among its holdings. This is a return to the name: Woodline Partners previously reported a position in JAZZ as recently as Q4 2025.

Woodline Partners first reported a position in JAZZ in Q2 2020 and has held it in 13 quarters since. The position peaked at $61.9M in Q2 2022. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Woodline Partners held 150,083 shares of Jazz Pharmaceuticals worth $36.2M as of Q2 2026.
  • Jazz Pharmaceuticals was a new Woodline Partners position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.11% of Woodline Partners's portfolio in Q2 2026, its #240 holding.
  • Woodline Partners first reported a position in Jazz Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
  • Woodline Partners's Jazz Pharmaceuticals position peaked at $61.9M in Q2 2022.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.